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Watson and Lewis, in their survey of expatriate doctors in asthma, it should also be noted that the use of inhaled medication in a number of African and Asian countries Africa and Asia published in this issue of Thorax, 1 highlight does not have the same tradition as in Western Europe the relatively low use of inhaled steroids in the treatment and this also contributes to a higher use of oral medication. of asthma throughout those regions. Glaxo Wellcome and
In developing countries with limited resources asthma is other manufacturers market both salbutamol and beclonot a priority chronic medical condition due to a lack of data methasone in aerosol and powder form in most countries on the prevalence of the disease and a limited knowledge of in Africa and Asia. The relatively low use of inhaled the disease. beclomethasone is consistent with our own internal market Prevalence data are now becoming available with well research.
publicised prevalence trials such as the ISAAC study which There are two reasons why, in particular, inhaled steroids has gathered data on the 6-7 and 13-14 year age groups are not more universally available. Firstly, the infrastructure in a large number of countries. As these and other data within a country may not favour adequate distribution of become more widely available they will be used by healthpharmaceuticals to some more remote areas. These logistic care professionals to support the prioritisation of asthma difficulties, complicated in some countries by civil unrest, as a chronic disease and establish it on the healthcare may prohibit the availability of pharmaceuticals on a wide agenda. If this is achieved, then a commitment to funding scale.
education and medication is likely to follow. The second and perhaps more important reason, as
The publication of the GINA guidelines in 1992, dehighlighted by Watson and Lewis, is that the metered dose veloped in collaboration with the WHO, has stimulated inhaler beclomethasone dipropionate, even sold at generic knowledge about the disease and has helped to bring it prices, can still account on a unit basis for approximately onto the agenda in many developing countries. These 20% of a monthly salary in some countries. Unlike tablets guidelines extensively review all aspects of the disease and which can be split from bulk, it is not possible to do this are seen as a framework for asthma management and, for a metered dose aerosol and so reduce the initial outlay moreover, give the opportunity for local interpretation in for the patients. It is unlikely that there is much scope for terms of treatment regimens which mirror drug availability. reduction of the unit cost of beclomethasone dipropionate Continued education and promotion of international inhalers as these are currently sold at generic prices. It guidelines will lead to an increase in the use of inhaled should be noted that the final selling price is not only in medication in the developing countries. It is therefore the hands of the manufacturer as customs duty, tax, and important that the availability of inhaled steroids does not distribution costs may account for a high proportion of inhibit their increasing acceptance in the treatment of the price to the patient. However, there is an increasing asthma in the developing world. awareness that the prescription of unit dose powder systems such as Rotacaps or Rotadisks allows a reduction in the Notwithstanding the political and economic issues
